How fasting affects stomach food with GLP-1 drugs
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how long fasting and temporarily stopping certain diabetes or weight-loss medications (like semaglutide or liraglutide) affects how much food stays in your stomach. It may help understand how these medications work in people who are overweight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is between 25 and 45, and your weight is mainly due to extra body fat.
- You do not have serious stomach or digestive problems (like slow stomach emptying or severe reflux).
- You have not had major stomach surgery (like gastric bypass) and do not have a stomach implant.
- You are willing to fast (no eating or drinking) for a while and eat only the meals we provide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a high dose of semaglutide (a medicine used for weight management) to see how it affects stomach emptying in people with excess weight. Participating may help understand how this treatment works and could lead to better options for weight loss.
This study is for people who have lost weight using GLP-1 injections (like semaglutide or tirzepatide) and are thinking about stopping them. It tests whether switching to an oral weight-loss medication can help you keep the weight off.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.